BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shalaby T, Fiaschetti G, Baumgartner M, Grotzer MA. MicroRNA signatures as biomarkers and therapeutic target for CNS embryonal tumors: the pros and the cons. Int J Mol Sci 2014;15:21554-86. [PMID: 25421247 DOI: 10.3390/ijms151121554] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Kutlay A, Aydin Son Y. Integrative Predictive Modeling of Metastasis in Melanoma Cancer Based on MicroRNA, mRNA, and DNA Methylation Data. Front Mol Biosci 2021;8:637355. [PMID: 34631789 DOI: 10.3389/fmolb.2021.637355] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Lambrou GI, Zaravinos A, Braoudaki M. Co-Deregulated miRNA Signatures in Childhood Central Nervous System Tumors: In Search for Common Tumor miRNA-Related Mechanics. Cancers (Basel) 2021;13:3028. [PMID: 34204289 DOI: 10.3390/cancers13123028] [Reference Citation Analysis]
3 Tang K, Gardner S, Snuderl M. The Role of Liquid Biopsies in Pediatric Brain Tumors. J Neuropathol Exp Neurol 2020;79:934-40. [PMID: 32766689 DOI: 10.1093/jnen/nlaa068] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
4 Santos-Ferreira CA, Abreu MT, Marques CI, Gonçalves LM, Baptista R, Girão HM. Micro-RNA Analysis in Pulmonary Arterial Hypertension: Current Knowledge and Challenges. JACC Basic Transl Sci 2020;5:1149-62. [PMID: 33294743 DOI: 10.1016/j.jacbts.2020.07.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
5 Haltom AR, Toll SA, Cheng D, Maegawa S, Gopalakrishnan V, Khatua S. Medulloblastoma epigenetics and the path to clinical innovation. J Neurooncol 2020;150:35-46. [PMID: 32816225 DOI: 10.1007/s11060-020-03591-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 El-Ahwany EGE, Mourad L, Zoheiry MMK, Abu-Taleb H, Hassan M, Atta R, Hassanien M, Zada S. MicroRNA-122a as a non-invasive biomarker for HCV genotype 4-related hepatocellular carcinoma in Egyptian patients. Arch Med Sci 2019;15:1454-61. [PMID: 31749873 DOI: 10.5114/aoms.2019.86621] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
7 Arriaga MA, Ding MH, Gutierrez AS, Chew SA. The Application of microRNAs in Biomaterial Scaffold-Based Therapies for Bone Tissue Engineering. Biotechnol J 2019;14:e1900084. [PMID: 31166084 DOI: 10.1002/biot.201900084] [Cited by in Crossref: 11] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
8 Afshar S, Seyedabadi S, Saidijam M, Samadi P, Mazaherilaghab H, Mahdavinezhad A. Long Non-coding Ribonucleic Acid as a Novel Diagnosis and Prognosis Biomarker of Bladder Cancer. Avicenna J Med Biochem 2019;7:28-34. [DOI: 10.34172/ajmb.2019.06] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
9 Cozar JM, Robles-Fernandez I, Rodriguez-Martinez A, Puche-Sanz I, Vazquez-Alonso F, Lorente JA, Martinez-Gonzalez LJ, Alvarez-Cubero MJ. The role of miRNAs as biomarkers in prostate cancer. Mutat Res Rev Mutat Res 2019;781:165-74. [PMID: 31416574 DOI: 10.1016/j.mrrev.2019.05.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
10 Borghei YS, Hosseini M. A New Eye Dual-readout Method for MiRNA Detection based on Dissolution of Gold nanoparticles via LSPR by CdTe QDs Photoinduction. Sci Rep 2019;9:5453. [PMID: 30931995 DOI: 10.1038/s41598-019-41898-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
11 Wang Y, Zhang G, Hao X, Ma Y, Ma M, Yan X, Jiang X, Bie F, Yuan N. RETRACTED: Potential biomarker for breast cancer screening: A systematic review and meta-analysis. Future Generation Computer Systems 2019;91:518-26. [DOI: 10.1016/j.future.2018.09.030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
12 Li SC, Vu LT, Luo JJ, Zhong JF, Li Z, Dethlefs BA, Loudon WG, Kabeer MH. Tissue elasticity bridges cancer stem cells to the tumor microenvironment through microRNAs: implications for a "watch-and-wait" approach to cancer. Curr Stem Cell Res Ther. 2017;12:455-470. [PMID: 28270089 DOI: 10.2174/1574888x12666170307105941] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
13 Zammit V, Baron B, Ayers D. MiRNA Influences in Neuroblast Modulation: An Introspective Analysis. Genes (Basel) 2018;9:E26. [PMID: 29315268 DOI: 10.3390/genes9010026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
14 Rapado-González Ó, Majem B, Muinelo-Romay L, Álvarez-Castro A, Santamaría A, Gil-Moreno A, López-López R, Suárez-Cunqueiro MM. Human salivary microRNAs in Cancer. J Cancer 2018;9:638-49. [PMID: 29556321 DOI: 10.7150/jca.21180] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 7.8] [Reference Citation Analysis]
15 Sharma S, Zuñiga F, Rice GE, Perrin LC, Hooper JD, Salomon C. Tumor-derived exosomes in ovarian cancer - liquid biopsies for early detection and real-time monitoring of cancer progression. Oncotarget 2017;8:104687-703. [PMID: 29262670 DOI: 10.18632/oncotarget.22191] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
16 Rostami Mogaddam M, Safavi Ardabili N, Shafaeei Y, Maleki N, Jafari N, Jafari A. Overexpression of Drosha, DiGeorge syndrome critical region gene 8 (DGCR8), and Dicer mRNAs in the pathogenesis of psoriasis. J Cosmet Dermatol 2017;16:e48-53. [DOI: 10.1111/jocd.12336] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
17 Singh R, Ramasubramanian B, Kanji S, Chakraborty AR, Haque SJ, Chakravarti A. Circulating microRNAs in cancer: Hope or hype? Cancer Lett 2016;381:113-21. [PMID: 27471105 DOI: 10.1016/j.canlet.2016.07.002] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 8.0] [Reference Citation Analysis]
18 Li Y, Jiang T, Shao L, Liu Y, Zheng C, Zhong Y, Zhang J, Chang Q. Mir-449a, a potential diagnostic biomarker for WNT group of medulloblastoma. J Neurooncol 2016;129:423-31. [PMID: 27406588 DOI: 10.1007/s11060-016-2213-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
19 Song C, Zhang L, Wang J, Huang Z, Li X, Wu M, Li S, Tang H, Xie X. High expression of microRNA-183/182/96 cluster as a prognostic biomarker for breast cancer. Sci Rep 2016;6:24502. [PMID: 27071841 DOI: 10.1038/srep24502] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 6.0] [Reference Citation Analysis]
20 Shalaby T, Grotzer MA. Tumor-Associated CSF MicroRNAs for the Prediction and Evaluation of CNS Malignancies. Int J Mol Sci 2015;16:29103-19. [PMID: 26690130 DOI: 10.3390/ijms161226150] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
21 Xie Y, Zhang L, Gao Y, Ge W, Tang P. The Multiple Roles of Microrna-223 in Regulating Bone Metabolism. Molecules 2015;20:19433-48. [PMID: 26512640 DOI: 10.3390/molecules201019433] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
22 Krishnan P, Ghosh S, Wang B, Li D, Narasimhan A, Berendt R, Graham K, Mackey JR, Kovalchuk O, Damaraju S. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer. BMC Genomics 2015;16:735. [PMID: 26416693 DOI: 10.1186/s12864-015-1899-0] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 8.0] [Reference Citation Analysis]
23 Zindy F, Lee Y, Kawauchi D, Ayrault O, Merzoug LB, Li Y, McKinnon PJ, Roussel MF. Dicer Is Required for Normal Cerebellar Development and to Restrain Medulloblastoma Formation. PLoS One 2015;10:e0129642. [PMID: 26091048 DOI: 10.1371/journal.pone.0129642] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
24 Gulino R, Forte S, Parenti R, Memeo L, Gulisano M. MicroRNA and pediatric tumors: Future perspectives. Acta Histochem 2015;117:339-54. [PMID: 25765112 DOI: 10.1016/j.acthis.2015.02.007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
25 Braoudaki M, Lambrou GI. MicroRNAs in pediatric central nervous system embryonal neoplasms: the known unknown. J Hematol Oncol 2015;8:6. [PMID: 25652781 DOI: 10.1186/s13045-014-0101-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
26 Braoudaki M, Lambrou GI, Giannikou K, Milionis V, Stefanaki K, Birks DK, Prodromou N, Kolialexi A, Kattamis A, Spiliopoulou CA, Tzortzatou-Stathopoulou F, Kanavakis E. Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasms. J Hematol Oncol 2014;7:96. [PMID: 25551588 DOI: 10.1186/s13045-014-0096-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]